| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/24/2005 | CA2538826A1 Immunoassay device with immuno-reference electrode |
| 03/24/2005 | CA2538801A1 Improved method and apparatus for aligning microbeads in order to interrogate the same |
| 03/24/2005 | CA2538797A1 Multiplex binding and activity assays |
| 03/24/2005 | CA2538778A1 Immunoassay device with improved sample closure |
| 03/24/2005 | CA2538495A1 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 03/24/2005 | CA2538461A1 The use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases |
| 03/24/2005 | CA2538442A1 Eukaryotic genes for modulating cell cycle progression |
| 03/24/2005 | CA2538440A1 Methods and device for adhesive control of internal cell organisation |
| 03/24/2005 | CA2538326A1 Apparatus and method for identifying therapeutic targets using a computer model |
| 03/24/2005 | CA2538288A1 Prion clearance using particulate metal oxides |
| 03/24/2005 | CA2538229A1 Treatment of rheumatoid arthritis with cd99 antagonists |
| 03/24/2005 | CA2538069A1 Effectors of innate immunity determination |
| 03/24/2005 | CA2537429A1 Method and device for detecting feline immunodeficiency virus |
| 03/24/2005 | CA2536735A1 Methods for determining cd8+ t-cell epitopes |
| 03/24/2005 | CA2535761A1 Parallel process for protein or virus separation from a sample |
| 03/24/2005 | CA2535221A1 Chimeric gabab receptor |
| 03/24/2005 | CA2503840A1 Direct detection method for products of cellular metabolism using tof-sims |
| 03/24/2005 | CA2482095A1 Method of mass spectrometry |
| 03/23/2005 | EP1517253A2 Method for design support of functional nucleic acids |
| 03/23/2005 | EP1517178A1 A process for preparing peptide nucleic acid probe using monomeric photoacid generator |
| 03/23/2005 | EP1517146A2 Flamingo (ant)agonists for the diagnosis and treatment of cancer |
| 03/23/2005 | EP1517145A1 Selectable length linear microarrays |
| 03/23/2005 | EP1517144A2 Method of identifying an antibody binding to and modulating the activity of a human vanilloid receptor |
| 03/23/2005 | EP1517134A1 Drug screening method and device using a Nipkow confocal scanner |
| 03/23/2005 | EP1517131A1 Method and apparatus for determining at least one property of a moving web |
| 03/23/2005 | EP1516881A2 Composition and method for modulating dendritic Cell-T cell interaction |
| 03/23/2005 | EP1516629A2 Humanized anti CD-11a antibodies |
| 03/23/2005 | EP1516620A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 03/23/2005 | EP1516190A1 Method for identifying agonists or antagonists for the g-protein coupled mas-like 1 receptor |
| 03/23/2005 | EP1516189A2 Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases |
| 03/23/2005 | EP1516188A2 Method for identifying and extracting endotoxin |
| 03/23/2005 | EP1516187A2 Hts-capable method and testing system for determining the interaction between a c-reactive protein and constituents that bind to a c-reactive protein |
| 03/23/2005 | EP1516186A1 A method for the detection of apoptosis |
| 03/23/2005 | EP1516185A2 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 03/23/2005 | EP1516182A1 Method for the determination of characteristics and/or the classification of circulating macrophages, and analysis arrangement for carrying out said method |
| 03/23/2005 | EP1516181A2 Container for taking samples and in particular blood samples |
| 03/23/2005 | EP1516180A1 Method and device for spectrophotometric analysis |
| 03/23/2005 | EP1516179A1 Methods and compositions for the diagnosis and treatment of demyelinating inflammatory disorders |
| 03/23/2005 | EP1516175A1 Biosensor array and method for operating a biosensor array |
| 03/23/2005 | EP1516174A1 Method and device for high sensitivity detection of the presence of dna and other probes |
| 03/23/2005 | EP1516173A1 Gas analyzer for measuring the flammability of mixtures of combustible gases and oxygen |
| 03/23/2005 | EP1516170A1 Lysing reagent, cartridge and automatic electronic cell counter for simultaneous enumeration of different types of white blood cells |
| 03/23/2005 | EP1516062A2 Homogenous assay for enzymatic activity |
| 03/23/2005 | EP1516061A1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor |
| 03/23/2005 | EP1516049A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/23/2005 | EP1516046A2 Genes encoding baeyer-villiger monooxygenases |
| 03/23/2005 | EP1515988A1 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 03/23/2005 | EP1515985A2 Methods of screening molecular libraries for active molecules that restore the function of mutant p53 |
| 03/23/2005 | EP1515982A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 03/23/2005 | EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 03/23/2005 | EP1515748A2 Anti-estrogen and immune modulator combinations for treating breast cancer |
| 03/23/2005 | EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 03/23/2005 | EP1515739A2 Methods for identifying compounds for regulating muscle mass or function using amylin receptors |
| 03/23/2005 | EP1515703A1 Pharmaceutical compositions with improved dissolution |
| 03/23/2005 | EP1515700A2 Controlled alignment of catalytically grown nanostructures in a large-scale synthesis process |
| 03/23/2005 | EP1461596A4 Direct write nanolithographic deposition of nucleic acids from nanoscopic tips |
| 03/23/2005 | EP1415152A4 Methods, apparatus, and computer programs for verifying the integrity of a probe |
| 03/23/2005 | EP1390759B1 Assay method for platelet-activating factor |
| 03/23/2005 | EP1345618B1 Chlorzoxazone for the treatment of psoriasis |
| 03/23/2005 | EP1328540B1 Immunoreactive peptidic ctl epitopes of human cytomegalovirus pp150 |
| 03/23/2005 | EP1322670A4 Electrochemiluminescence from acridan compounds |
| 03/23/2005 | EP1317672B1 Method for measuring the activity of the blood clotting factor xiiia |
| 03/23/2005 | EP1297336B1 Immunoassay and immunoassay apparatus |
| 03/23/2005 | EP1254250B1 Method for the evaluation of implantable materials |
| 03/23/2005 | EP1247093B1 Screening assays using intramitochondrial calcium |
| 03/23/2005 | EP1228373B1 Diagnosis and therapy of cancer using sgp28-related molecules |
| 03/23/2005 | EP1226422A4 Surface enhanced spectroscopy-active composite nanoparticles |
| 03/23/2005 | EP1185703B1 CoRT-PCR ASSAY FOR THE DISCRIMINATION OF ENDOGENOUS REVERSE TRANSCRIPTASE ACTIVITY IN EUKARYOTIC CELL LINES FROM INFECTIOUS RETROVIRUS CONTAMINATION |
| 03/23/2005 | EP1125147A4 Portable fluid screening device and method |
| 03/23/2005 | EP1114166B1 Method for down-regulating osteoprotegerin ligand activity |
| 03/23/2005 | EP1098647B1 Compounds and compositions for treating tissue ischemia |
| 03/23/2005 | EP1091973A4 Multiparametric fluorescence in situ hybridization |
| 03/23/2005 | EP1021714A4 Method and apparatus for measuring lipid peroxidation in biological fluids and suspensions of tissues |
| 03/23/2005 | EP1019719B1 Method for determining the state of substances containing keratin and suitable devices and means therefor |
| 03/23/2005 | EP1015642A4 Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 03/23/2005 | EP1012311B1 G protein chimeras |
| 03/23/2005 | EP1012241B1 Screening assays for g protein coupled receptor agonists and antagonists |
| 03/23/2005 | EP0939813B1 Breast carcinoma-associated gene |
| 03/23/2005 | EP0845005B1 Traf inhibitors |
| 03/23/2005 | EP0804613B1 Dap-2 tumor suppressor gene, protein encoded thereby and use of said gene and protein |
| 03/23/2005 | EP0772456B1 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 03/23/2005 | EP0574579B1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 03/23/2005 | CN2687673Y Chip utensil |
| 03/23/2005 | CN2687672Y Road crack auto-detecting device |
| 03/23/2005 | CN2687671Y Powder wettability rapid measuring device |
| 03/23/2005 | CN2687670Y Furnace atmosphere detecting device |
| 03/23/2005 | CN2687652Y Urine sample collecting device |
| 03/23/2005 | CN1599867A Immunocytokines with modulated selectivity |
| 03/23/2005 | CN1599865A 生物传感器 Biosensor |
| 03/23/2005 | CN1599799A Identification of genes involved in restenosis and in atherosclerosis |
| 03/23/2005 | CN1599753A Gene regulatory peptides |
| 03/23/2005 | CN1599752A Nucleic protein 'Shoca'-a component of wnt signal transmission channel |
| 03/23/2005 | CN1599750A Cytotoxic protein and utilization thereof |
| 03/23/2005 | CN1599622A Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease |
| 03/23/2005 | CN1599618A Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/23/2005 | CN1598694A Method of forming nano pattern and manufacturing cnt-bio-nano chip |
| 03/23/2005 | CN1598592A Three-dimensional space fixed-point separation determine method for material component distribution |
| 03/23/2005 | CN1598589A Microfluid dynamic mixer, mixing pond mould in chip and driving method thereof |
| 03/23/2005 | CN1598588A Method for modifing protein chip surface |
| 03/23/2005 | CN1598587A Method for fixing protein on surface of protein chip |